从广州到慕尼黑（38）

1月14日下午2:00，仁医医疗三人团队到达慕尼黑工业大学附属医院拜访血液与肿瘤科Lorenzen教授。Lorenzen教授专注于胃肠道癌症多模式治疗、实体瘤治疗反应评估及癌症I期临床试验等，并担任多个国内、国际学术职位。Lorenzen教授是德国癌症协会肿瘤内科学工作组（AIO）胃癌工作组主席，慕尼黑工业大学附属医院早期临床试验组（ECTU）负责人。她所在的血液与肿瘤科为患者提供的诊疗方案达到了最新的国际化水平，科室配备有专业团队为每位肿瘤患者量身打造最现代化的治疗方案。科室血液与免疫分型实验室的干细胞实验室还获得了巴伐利亚州政府认证。此外，该科室十分重视院内外的多学科合作。院内，他们与跨学科肿瘤治疗中心（TTZ）密切配合；院外，他们也与慕尼黑综合癌症中心（CCCM）及德国癌症转化研究联合学会（DKTK）紧密联系。据Lorenzen教授介绍，科室团队还与法兰克福大学肿瘤疾病中心（UCT）的肿瘤临床研究所（IKF）合作，在上胃肠道疾病领域进行了许多临床实验。Lorenzen教授本人同样活跃于临床研究，并发表了多篇高影响力学术论文，积极推动全球肿瘤医学发展。2024年，Lorenzen教授加入了仁医医疗的德国临床医学MD博士项目合作，2024年11月8日教授与来自贵阳的罗医生进行了面试，并在今年1月为她发了邀请函，正式接收她为临床医学MD博士，她将积极帮助罗医生于2025年3月份申请中国留学基金委（CSC）奖学金。2025年11月Lorenzen教授将来到中国参加第五届中欧医院管理学科建设人才培养全球论坛，她表示非常期待来到中国与中国同道们交流分享相关经验。

At 2 p.m. on the afternoon of January 14 , the team of three from Gloryren arrived at the Klinikum Rechts der Isar of Technical University of Munich to visit Prof. Lorenzen of the Department of Hematology and Oncology. Prof. Lorenzen focuses on the response evaluation in solid tumour therapy, multimodality treatment of gastrointestinal cancer and Phase I clinical trials. She also holds many positions in national and international scientific organizations. Prof. Lorenzen is the Vice Chair of the Gastric Cancer Task Force of the Internal Oncology Working Group (AIO) of German Cancer Society and the Head of the Early Clinical Trial Unit (ECTU) of the Klinikum Rechts der Isar of Technical University of Munich. The Department of Hematology and Oncology, where Prof. Lorenzen works in, offers patient care with the latest international level. The department is equipped with a professional team to provide the most modern treatment plan for each patient. The stem cell laboratory of the department’s Hematology and Immunophenotyping Laboratory is certified by the Bavarian Government. Additionally, the department places great value on interdisciplinary cooperation. Internally, they establish close cooperation with the Interdisciplinary Tumor Therapy Center (TTZ). Externally, they keep close contact with Comprehensive Cancer Center Munich (CCCM) and the German Consortium for Translational Cancer Research (DKTK). According to Prof. Lorenzen, the department conducts many clinical trials on upper gastrointestinal tumors in collaboration with the Institute for Clinical Cancer Research (IKF) of the Comprehensive Cancer Centers of the University Hospital Frankfurt (UCT).Prof. Lorenzen has been active in clinical research and has published many high-impact academic papers, actively promoting the development of oncology from a global perspective. In 2024, Prof. Lorenzen established a cooperation with Gloryren on MD project and interviewed Doctor Luo from Guiyang, Guizhou Province, on November 8, 2024.In January, she issued an invitation for Doctor Luo and accepted her as an MD student, and she will support Luo to apply for the CSC scholarship in March 2025.Prof. Lorenzen will visit China to attend the 5th Sino-Euro Global Forum on Hospital Management, Specialty Construction and Talent Cultivation in November 2025. She is looking forward to visiting China and to sharing her valuable insights with Chinese colleagues.